Leponex



Indications and Reactions:

Role Indications Reactions
Primary
Schizophrenia 45.9%
Psychotic Disorder 10.9%
Schizophrenia, Paranoid Type 7.7%
Depression 5.7%
Schizoaffective Disorder 4.6%
Anxiety 4.5%
Hypertension 2.6%
Bipolar Disorder 2.5%
Epilepsy 2.0%
Mental Disorder 2.0%
Parkinson's Disease 2.0%
Insomnia 1.5%
Dementia 1.4%
Schizophrenia, Disorganised Type 1.2%
Constipation 1.0%
Hallucination 1.0%
Bipolar I Disorder 0.9%
Major Depression 0.9%
Agitation 0.8%
Atrial Fibrillation 0.8%
White Blood Cell Count Decreased 14.3%
White Blood Cell Count Increased 12.9%
Pyrexia 8.2%
Somnolence 8.2%
Weight Increased 7.3%
Vomiting 5.7%
Urinary Tract Infection 5.0%
Tachycardia 4.1%
Weight Decreased 4.1%
Surgery 3.9%
Tremor 3.4%
Death 3.2%
Neutropenia 2.9%
Transaminases Increased 2.7%
Obsessive-compulsive Disorder 2.5%
Psychotic Disorder 2.5%
Speech Disorder 2.5%
Suicide Attempt 2.5%
Vertigo 2.3%
Electrocardiogram Qt Prolonged 2.0%
Secondary
Schizophrenia 23.7%
Product Used For Unknown Indication 14.9%
Drug Use For Unknown Indication 14.7%
Schizophrenia, Paranoid Type 7.4%
Psychotic Disorder 6.7%
Schizophrenia, Undifferentiated Type 4.1%
Depression 3.3%
Ill-defined Disorder 3.0%
Parkinson's Disease 2.6%
Anxiety 2.6%
Schizoaffective Disorder 2.5%
Bipolar Disorder 2.3%
Epilepsy 2.2%
Hypertension 1.9%
Mental Disorder 1.6%
Insomnia 1.5%
Contraception 1.4%
Laxative Supportive Care 1.4%
Hallucination 1.0%
Pain 1.0%
White Blood Cell Count Decreased 12.5%
Weight Increased 11.3%
White Blood Cell Count Increased 9.2%
Vertigo 6.5%
Psychiatric Symptom 6.0%
Somnolence 5.9%
Sinus Tachycardia 5.1%
Tremor 5.0%
Pyrexia 4.2%
Vomiting 4.1%
Upper Respiratory Tract Infection 3.9%
Weight Decreased 3.8%
Tachycardia 3.2%
Myopathy 3.0%
Supraventricular Tachycardia 3.0%
Sudden Death 2.9%
Urinary Tract Infection 2.9%
Neutropenia 2.7%
Psychotic Disorder 2.4%
Schizophrenia 2.4%
Concomitant
Product Used For Unknown Indication 19.5%
Drug Use For Unknown Indication 16.6%
Schizophrenia 14.1%
Parkinson's Disease 9.5%
Psychotic Disorder 7.3%
Anorexia Nervosa 5.3%
Schizophrenia, Paranoid Type 4.2%
Depression 3.2%
Bipolar Disorder 2.7%
Bipolar I Disorder 2.7%
Major Depression 2.0%
Obsessive-compulsive Personality Disorder 2.0%
Epilepsy 1.8%
Abnormal Behaviour 1.5%
Affective Disorder 1.3%
Attention Deficit/hyperactivity Disorder 1.3%
Deep Vein Thrombosis 1.3%
Schizoaffective Disorder 1.3%
Colitis Ulcerative 1.2%
Crohn's Disease 1.2%
Supraventricular Extrasystoles 23.4%
Weight Increased 16.1%
Eyelid Oedema 5.1%
Overdose 5.1%
Parkinsonism 4.4%
Psychotic Disorder 4.4%
Somnolence 4.4%
Transaminases Increased 4.4%
Nervous System Disorder 3.6%
Hepatitis Acute 2.9%
Intentional Self-injury 2.9%
Leukopenia 2.9%
Neutropenia 2.9%
Overweight 2.9%
Platelet Count Decreased 2.9%
Visual Impairment 2.9%
Bronchitis 2.2%
Death 2.2%
Drug Dose Omission 2.2%
Hepatitis 2.2%
Interacting
Schizophrenia 23.5%
Drug Use For Unknown Indication 20.2%
Hallucination 8.1%
Insomnia 7.7%
Delirium 6.5%
Anxiety 4.9%
Product Used For Unknown Indication 4.9%
Schizophrenia, Paranoid Type 4.5%
Mania 3.6%
Psychotic Disorder 2.8%
Depression 2.0%
Hallucination, Visual 2.0%
Schizoaffective Disorder 1.6%
Abnormal Behaviour 1.2%
Agitation 1.2%
Myocardial Infarction 1.2%
Parkinson's Disease 1.2%
Type 2 Diabetes Mellitus 1.2%
Aggression 0.8%
Arrhythmia 0.8%
Drug Interaction 25.4%
Polydipsia 12.7%
Withdrawal Syndrome 11.3%
Tachycardia 8.5%
Somnolence 5.6%
Akathisia 4.2%
Liver Function Test Abnormal 4.2%
White Blood Cell Count Increased 4.2%
Hepatitis Acute 2.8%
Psychotic Disorder 2.8%
Shock 2.8%
Suicide Attempt 2.8%
Ventricular Extrasystoles 2.8%
Electrocardiogram Qt Prolonged 1.4%
Hepatic Enzyme Increased 1.4%
Hypotension 1.4%
Orthostatic Hypotension 1.4%
Pancytopenia 1.4%
Pharyngeal Oedema 1.4%
Poisoning 1.4%